A detailed history of Ameriprise Financial Inc transactions in Biote Corp. stock. As of the latest transaction made, Ameriprise Financial Inc holds 21,621 shares of BTMD stock, worth $54,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,621
Previous 32,529 33.53%
Holding current value
$54,484
Previous $130,000 50.77%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$2.82 - $4.55 $30,760 - $49,631
-10,908 Reduced 33.53%
21,621 $64,000
Q2 2025

Aug 14, 2025

BUY
$3.25 - $4.28 $8,895 - $11,714
2,737 Added 9.19%
32,529 $130,000
Q1 2025

May 14, 2025

SELL
$3.23 - $6.2 $20,743 - $39,816
-6,422 Reduced 17.73%
29,792 $99,000
Q4 2024

Feb 14, 2025

BUY
$5.04 - $6.93 $16,889 - $23,222
3,351 Added 10.2%
36,214 $226,000
Q3 2024

Nov 14, 2024

BUY
$5.33 - $8.36 $104,627 - $164,106
19,630 Added 148.34%
32,863 $183,000
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $71,987 - $98,850
13,233 New
13,233 $98,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $19.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.